Distinguished in Heart Failure

Peter J. Nordbeck

Oberdürrbacher Str. 6, 
Wuerzburg, BY, DE 
Distinguished in Heart Failure
Oberdürrbacher Str. 6, 
Wuerzburg, BY, DE 
OverviewLocationsClinical Research

Overview

Peter Nordbeck practices in Wuerzburg, Germany. Mr. Nordbeck is rated as a Distinguished expert by MediFind in the treatment of Heart Failure. His top areas of expertise are Fabry Disease, Cardiogenic Shock, Heart Failure, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

His clinical research consists of co-authoring 185 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 34 articles and participated in 5 clinical trials in the study of Heart Failure.

Gender
Male

Locations

Oberdürrbacher Str. 6, Wuerzburg, BY 97080, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial
Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial
Enrollment Status: Active_not_recruiting
Publish Date: July 22, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Prospective Randomised CompArative Trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation With and Without DeFibrillation Testing
A Prospective Randomised CompArative Trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation With and Without DeFibrillation Testing
Enrollment Status: Active_not_recruiting
Publish Date: February 03, 2025
Intervention Type: Procedure
Study Phase: Not Applicable
A Phase 3, Open-label Study to Evaluate the Efficacy and Safety of REPLAGAL® in Treatment-naïve Subjects With Fabry Disease
A Phase 3, Open-label Study to Evaluate the Efficacy and Safety of REPLAGAL® in Treatment-naïve Subjects With Fabry Disease
Enrollment Status: Terminated
Publish Date: June 17, 2024
Intervention Type: Drug
Study Drug: Replagal
Study Phase: Phase 3
Cardiac Contractility Modulation Therapy in Subjects With Heart Failure With Preserved Ejection Fraction
Cardiac Contractility Modulation Therapy in Subjects With Heart Failure With Preserved Ejection Fraction
Enrollment Status: Completed
Publish Date: April 23, 2024
Intervention Type: Device
Study Phase: Not Applicable
Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry (SMART Registry)
Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry (SMART Registry)
Enrollment Status: Completed
Publish Date: October 25, 2023
Intervention Type: Device
MOre REsponse on Cardiac Resynchronization Therapy (CRT) With MultiPoint Pacing (MPP)
MOre REsponse on Cardiac Resynchronization Therapy (CRT) With MultiPoint Pacing (MPP)
Enrollment Status: Terminated
Publish Date: May 17, 2023
Intervention Type: Device
Study Phase: Not Applicable
Randomized Trial to Study the Efficacy and Adverse Effects of the Subcutaneous and Transvenous Implantable Cardioverter Defibrillator (ICD) in Patients With a Class I or IIa Indication for ICD Without an Indication for Pacing
Randomized Trial to Study the Efficacy and Adverse Effects of the Subcutaneous and Transvenous Implantable Cardioverter Defibrillator (ICD) in Patients With a Class I or IIa Indication for ICD Without an Indication for Pacing
Enrollment Status: Unknown
Publish Date: May 09, 2023
Intervention Type: Device
Study Phase: Not Applicable
BIO|MASTER.Edora Family Study
BIO|MASTER.Edora Family Study
Enrollment Status: Completed
Publish Date: May 12, 2020
Intervention Type: Device
Safety and Electrical Performances Evaluation of Navigo Leads Equipped With IS4 Connector
Safety and Electrical Performances Evaluation of Navigo Leads Equipped With IS4 Connector
Enrollment Status: Unknown
Publish Date: September 17, 2019
Intervention Type: Device
Study Phase: Not Applicable
BIO|MASTER.Ilivia Family / Plexa
BIO|MASTER.Ilivia Family / Plexa
Enrollment Status: Completed
Publish Date: May 22, 2019
Intervention Type: Device
Study Phase: Not Applicable
Assessment of Pacing Stimulus Conduction and Latency Measurements in CRT-D Patients
Assessment of Pacing Stimulus Conduction and Latency Measurements in CRT-D Patients
Enrollment Status: Terminated
Publish Date: November 28, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 10 Less Clinical Trials

185 Total Publications

Long-Term Outcomes of the DanGer Shock Trial.
Long-Term Outcomes of the DanGer Shock Trial.
Journal: The New England journal of medicine
Published: September 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Nordbeck's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 27 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile